Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol (Q46670557)

24 December 2017

title

Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol (English)

1 reference

24 December 2017

0 references

1 reference

6

Benoit Dawant

1 reference

24 December 2017

author name string

Robert M Kessler

1

1 reference

24 December 2017

Mohammad Sib Ansari

2

1 reference

24 December 2017

Patrizia Riccardi

3

1 reference

24 December 2017

Rui Li

4

1 reference

24 December 2017

Karuna Jayathilake

5

1 reference

24 December 2017

Herbert Y Meltzer

7

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

24 December 2017

published in

Neuropsychopharmacology

1 reference

24 December 2017

volume

30

1 reference

24 December 2017

issue

12

1 reference

24 December 2017

page(s)

2283-2289

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300836

exact match

0 references

cites work

Combined 5-HT2/D2 receptor blockade inhibits the firing rate of SNR neurons in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

An animal model of extrapyramidal side effects induced by antipsychotic drugs: relationship with D2 dopamine receptor occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Dopamine receptors in the substantia nigra are involved in the regulation of muscle tone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Parametric imaging of ligand-receptor binding in PET using a simplified reference region model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Raclopride and chlorpromazine, but not clozapine, increase muscle rigidity in the rat: relationship with D2 dopamine receptor occupancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Comparison of methods for analysis of clinical [11C]raclopride studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Multimodality image registration by maximization of mutual information.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Serotonin receptors: their key role in drugs to treat schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Effects of olanzapine on regional C-Fos expression in rat forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Significant dissociation of brain and plasma kinetics with antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Effects of acute and chronic administration of olanzapine in comparison to clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Extrastriatal dopamine D 2/3 receptor density and distribution in drug-naive schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Multi-modal volume registration by maximization of mutual information

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

In vivo 123 I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

7 January 2021

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

7 January 2021

5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

7 January 2021

Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

7 January 2021

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

7 January 2021

Analysis of emission tomographic scan data: limitations imposed by resolution and background

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

7 January 2021

Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300836

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300836

1 reference

24 December 2017

Dimensions Publication ID

0 references

1 reference

24 December 2017